home / stock / tbph / tbph quote
Last: | $9.34 |
---|---|
Change Percent: | 0.76% |
Open: | $9.13 |
Close: | $9.34 |
High: | $9.38 |
Low: | $9.02 |
Volume: | 433,019 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$9.34 | $9.13 | $9.34 | $9.38 | $9.02 | 433,019 | 04-19-2024 |
$9.2 | $9.51 | $9.2 | $9.52 | $9.15 | 362,260 | 04-18-2024 |
$9.52 | $9.68 | $9.52 | $9.85 | $9.49 | 307,877 | 04-17-2024 |
$9.69 | $9.88 | $9.69 | $9.88 | $9.585 | 472,501 | 04-16-2024 |
$9.92 | $9.53 | $9.92 | $9.98 | $9.4881 | 517,519 | 04-15-2024 |
$9.61 | $9.55 | $9.61 | $10.44 | $9.45 | 783,427 | 04-12-2024 |
$8.93 | $9.5 | $8.93 | $9.61 | $8.825 | 472,613 | 04-11-2024 |
$9.54 | $9.35 | $9.54 | $9.55 | $9.18 | 468,773 | 04-10-2024 |
$9.48 | $9.48 | $9.48 | $9.63 | $9.3 | 507,606 | 04-09-2024 |
$9.47 | $9.29 | $9.47 | $9.51 | $9.21 | 371,772 | 04-08-2024 |
$9.31 | $9.14 | $9.31 | $9.33 | $9.05 | 346,351 | 04-05-2024 |
$9.14 | $9.37 | $9.14 | $9.42 | $9.05 | 438,871 | 04-04-2024 |
$9.29 | $9.07 | $9.29 | $9.32 | $9 | 476,529 | 04-03-2024 |
$9.1 | $8.93 | $9.1 | $9.12 | $8.79 | 458,264 | 04-02-2024 |
$9.03 | $8.99 | $9.03 | $9.04 | $8.75 | 317,724 | 04-01-2024 |
$8.97 | $9 | $8.97 | $9 | $8.77 | 401,710 | 03-29-2024 |
$8.97 | $9 | $8.97 | $9 | $8.77 | 401,710 | 03-28-2024 |
$9.01 | $8.85 | $9.01 | $9.02 | $8.79 | 320,008 | 03-27-2024 |
$8.82 | $8.82 | $8.82 | $8.95 | $8.75 | 296,175 | 03-26-2024 |
$8.76 | $8.92 | $8.76 | $9.09 | $8.65 | 365,382 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Theravance Biopharma Inc. Company Name:
TBPH Stock Symbol:
NASDAQ Market:
2024-04-12 08:00:07 ET Julian Harrison from BTIG issued a price target of $21.00 for TBPH on 2024-04-12 06:36:00. The adjusted price target was set to $21.00. At the time of the announcement, TBPH was trading at $8.93. The overall price target consensus is at $14.00 with...
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024 PR Newswire DUBLIN , ...